NASDAQ$RMTI
Rockwell Medical Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Reported record net sales and gross profit, and raised 2024 guidance.
Rockwell Medical reported record net sales of $22.7 million for Q1 2024, a 15% increase year-over-year. Gross profit also reached a record $3.1 million, up 18% from the same period last year. The company has raised its full-year 2024 guidance for net sales, gross profit, and adjusted EBITDA.
- Net sales increased by 15% year-over-year, reaching $22.7 million.
- Gross profit increased by 18% year-over-year, reaching $3.1 million.
- The company has revised its guidance for 2024 upward.
- Rockwell Medical was certified as a Great Place to Work® for the second year in a row.
Headline financials
Revenue & EPS history
Rockwell Medical · Revenue · Quarterly
$22.7M
Forward guidance
Rockwell Medical updated its guidance for the full year 2024, projecting net sales between $90.0M and $94.0M, gross profit between $13.0M and $15.0M, and adjusted EBITDA between $0.5M and $1.0M.
Tailwinds
- Net Sales: $90.0M to $94.0M (13% to 18% increase over 2023)
- Gross Profit: $13.0M to $15.0M (49% to 72% increase over 2023)
- Gross Margin: 4 to 6 percentage point increase over 2023
- Adjusted EBITDA: $0.5M to $1.0M (113% to 126% increase over 2023)
- Net sales to grow in the mid-to-high single digits in 2025 and beyond.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2024
-3.1%
Avg return
Earnings day
-3.3%
Avg return
5 days after
-3.0%
Avg return
30 days after
38%
24 / 63 earnings
Positive
+28.2%
Q3 2022
Best reaction
-43.4%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | -13.0% | -11.3% | — | |
| Q1 2026 | -3.6% | +2.8% | -18.2% | |
| Q3 2025 | -9.2% | -17.1% | -12.4% | |
| Q1 2025 | -6.4% | -9.8% | -11.6% | |
| Q4 2024 | -20.5% | -31.8% | -41.5% | |
| Q3 2024 | -43.4% | -49.2% | -55.5% | |
| Q2 2024 | +22.6% | +35.6% | +68.4% | |
| Q1 2024 | +0.6% | +4.1% | +8.2% | |
| Q4 2023 | +3.6% | +0.0% | -12.1% | |
| Q3 2023 | +12.2% | +5.1% | -11.2% | |
| Q2 2023 | -7.4% | -25.8% | -28.5% | |
| Q1 2023 | -4.5% | -3.7% | +71.8% | |
| Q4 2022 | +14.6% | +18.4% | +74.7% | |
| Q3 2022 | +28.2% | +19.4% | +0.0% | |
| Q2 2022 | +12.0% | +7.1% | -14.1% | |
| Q1 2022 | +3.0% | -17.3% | -34.7% | |
| Q4 2021 | -13.6% | -11.4% | -27.3% | |
| Q3 2021 | -7.7% | -7.7% | -21.2% | |
| Q2 2021 | -6.2% | -10.8% | -4.6% | |
| Q1 2021 | -2.2% | -4.3% | +0.0% | |
| Q4 2020 | +4.5% | -1.8% | -13.5% | |
| Q3 2020 | +1.1% | +5.6% | +33.7% | |
| Q2 2020 | +4.2% | +0.0% | -26.3% | |
| Q1 2020 | -4.7% | -12.9% | -9.0% | |
| Q4 2019 | -42.7% | -25.0% | -22.6% | |
| Q3 2019 | +5.4% | +12.4% | +23.7% | |
| Q2 2019 | -5.6% | +2.0% | +9.3% | |
| Q1 2019 | -7.5% | -11.9% | -25.6% | |
| Q4 2018 | +3.0% | +23.9% | +4.7% | |
| Q3 2018 | +8.9% | +12.3% | -16.2% | |
| Q2 2018 | -15.5% | -12.4% | -13.6% | |
| Q1 2018 | -2.5% | +5.8% | -8.8% | |
| Q4 2017 | -17.5% | -18.3% | -14.1% | |
| Q3 2017 | +9.6% | +11.6% | +3.4% | |
| Q2 2017 | -4.2% | -1.5% | -5.4% | |
| Q1 2017 | -1.2% | -9.1% | +9.3% | |
| Q4 2016 | +10.0% | +10.2% | +10.6% | |
| Q3 2016 | -20.5% | -3.5% | +27.3% | |
| Q2 2016 | -8.9% | -8.1% | -10.2% | |
| Q1 2016 | +19.7% | — | — | |
| Q4 2015 | -36.8% | — | — | |
| Q3 2015 | -10.5% | — | — | |
| Q2 2015 | +11.5% | — | — | |
| Q1 2015 | +12.9% | — | — | |
| Q4 2014 | -6.6% | — | — | |
| Q3 2014 | +5.7% | — | — | |
| Q2 2014 | +0.1% | — | — | |
| Q1 2014 | -8.5% | — | — | |
| Q3 2013 | -0.8% | — | — | |
| Q2 2013 | +0.6% | — | — | |
| Q1 2013 | -7.6% | — | — | |
| Q4 2012 | -19.9% | — | — | |
| Q3 2012 | -3.3% | — | — | |
| Q2 2012 | -6.4% | — | — | |
| Q1 2011 | -0.2% | — | — | |
| Q1 2012 | +1.0% | — | — | |
| Q4 2011 | -4.4% | — | — | |
| Q3 2011 | -9.3% | — | — | |
| Q3 2010 | -9.3% | — | — | |
| Q2 2011 | -0.1% | — | — | |
| Q2 2010 | -0.1% | — | — | |
| Q4 2010 | -1.4% | — | — | |
| Q1 2010 | +3.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro